{
  "ticker": "MYX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02965300",
  "id": "02965300",
  "pages": 7,
  "price_sensitive": false,
  "date": "20250702",
  "time": "1753",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250702/pdf/06ldgpn0sw507v.pdf",
  "summary": "### Material Information Summary (Form 605 - Ceasing to be a Substantial Holder)  \n\n- **Company**: Mayne Pharma Group Limited (ASX: MYX)  \n- **Substantial Holder**: Mitsubishi UFJ Financial Group, Inc. (MUFG)  \n- **Key Change**: MUFG ceased to be a substantial holder on **1 July 2025**.  \n- **Transactions by Associates (Morgan Stanley & First Sentier Investors)**:  \n  - **Total Shares Sold**: ~119,368 ordinary shares (aggregate across multiple transactions).  \n  - **Total Shares Purchased**: ~24,683 ordinary shares (aggregate across multiple transactions).  \n- **Net Impact**: Significant sell-down (~94,685 net shares) leading to loss of substantial holding status.  \n\n*Note: No pricing or timetables provided\u2014focus on ownership change.*",
  "usage": {
    "prompt_tokens": 6967,
    "completion_tokens": 181,
    "total_tokens": 7148,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-02T08:39:22.726623"
}